BRCA2 (phospho Ser2095) antibody

GeneTex

BRCA2 (phospho Ser2095) antibody

9

WB: 1:500-1:2000. ICC/IF: 1:100-1:500. IHC-P: 1:50-1:200. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.

ImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin

Research Use Only

Polyclonal

1 mg/ml

Unconjugated

BRCA2

BRCA2 DNA repair associated

BRCA1/BRCA2-containing complex, subunit 2; BRCC2; breast and ovarian cancer susceptibility gene, early onset; breast and ovarian cancer susceptibility protein 2; breast cancer 2 tumor suppressor; breast cancer 2, early onset; breast cancer type 2 susceptibility protein; BROVCA2; FACD; FAD; FAD1; FANCD; FANCD1; Fanconi anemia group D1 protein; GLM3; mutant BRCA2; PNCA2; truncated BRCA2 DNA repair associated; truncated BRCA2 DNA repair-associated protein; truncated breast cancer 2; truncated DNA repair-associated BRCA2; truncated DNA repair-associated protein; XRCC11

Rabbit

IgG

Breast cancer type 2 susceptibility protein

Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, Dec 2008]

-20°C or -80°C,2°C to 8°C

12352203